These three RNA-seq-only mutations (EGFR-A702S, TP53-I254S and TSC2-V296fs) are thus cancer-driver candidates found only by RNA-seq and should therefore motivate the use of RNA-seq as they were missed by WES. This evidence concerns the gene TP53 and cancer.